Maria Francesca Morelli

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study

P. Queirolo, M. Del Vecchio, V. Chiarion Sileni, 2023, Cancers.